Solar Pharmaceuticals Inc is categorized under Commercial Physical Research in Fort Lauderdale, FL and active since 2001.
Solar Pharmaceuticals Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Physical Research business, which does work in the B2B market, and is classified as a Commercial Physical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Larry Solomon at the company’s single location by writing to 5310 Nw 33rd Avenue # 118, Fort Lauderdale, Florida FL 33309 or by phoning (765) 932-4243. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Solar Pharmaceuticals Inc |
| Contact Person: | Larry Solomon |
| Address: | 5310 Nw 33rd Avenue # 118, Fort Lauderdale, Florida 33309 |
| Phone Number: | (765) 932-4243 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Physical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Solar Pharmaceuticals Inc was started in 2001 to provide professional Commercial Physical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Larry Solomon for inquiries that concern Solar Pharmaceuticals Inc by calling the company number (765) 932-4243, as your correspondence is most welcome. Additionally, the physical location of the single location of Solar Pharmaceuticals Inc can be found at the coordinates as well as the street address 5310 Nw 33rd Avenue # 118 in Fort Lauderdale, Florida 33309.
For its online presence, you may visit Solar Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.